Alvaro Alencar, Md

This study is testing a combination of two drugs, zanubrutinib and tafasitamab, for people with mantle cell lymphoma, a type of blood cancer. The first part aims to find the safest and most effective dose. The second part will see how well this dose combination works to put the c…